Nanopublications

@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw> .
@prefix sub: <http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nkg: <https://w3id.org/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_14320> schema:possibleTreatment sub:medtherapy .
  sub:medtherapy prov:wasDerivedFrom sub:quote ;
    schema:drug <http://identifiers.org/drugbank/DB00715> ;
    schema:targetPopulation sub:targetpop ;
    nkg:indicationType schema:TreatmentIndication .
  sub:quote prov:value "Paroxetine tablets are indicated for the treatment of Generalized Anxiety Disorder (GAD), as defined in DSM-IV. The efficacy of paroxetine tablets in the treatment of GAD was established in two 8-week placebo-controlled trials in adults with GAD. Paroxetine tablets have not been studied in children or adolescents with Generalized Anxiety Disorder" ;
    prov:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .
  sub:targetpop schema:audienceType "adults" ;
    schema:requiredMinAge "18" .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "ROXVKkTSGrlatjijTvXuemV1zxouzzJhEXgXWBQtVkDKgc0AqT22yW3daCgCJWpMx6Jwj/J0C+R32RKXQqGbHls2u+J+FtfG9TpknGUDnf4+y2hjB6b7YT+iTTkB8tLbKHAINo/evdHCmTMXIQQxKgdHBgbNruTS/aQtCNiW+Q4=" ;
    npx:hasSignatureTarget this: .
  this: dcterms:created "2021-04-17T12:10:41.108+02:00"^^xsd:dateTime ;
    dcterms:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA56KBJXCfPObqVb3hNCSbbohzz02_VEW2PxnmyIQ0Hus> .
}